acetylcysteine and enalaprilat anhydrous

acetylcysteine has been researched along with enalaprilat anhydrous in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's1 (11.11)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chin, SA; Fawcett, JP; Walker, RJ1
Goldschmidt, JE; Tallarida, RJ1
Lawson, DL; Mehta, JL; Mehta, P; Nichols, WW1
Mollace, V; Salvemini, D; Sessa, WC; Vane, JR1
Carbonell, LF; Inglés, AC; Quesada, T; Ruiz, FJ; Salom, MG; Vicente, E1
Sun, HX; Yu, DJ; Yu, M; Zheng, Y1

Reviews

1 review(s) available for acetylcysteine and enalaprilat anhydrous

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for acetylcysteine and enalaprilat anhydrous

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Captopril does not protect against renal oxidative injury.
    Renal failure, 1992, Volume: 14, Issue:4

    Topics: Acetylcysteine; Animals; Captopril; Drug Interactions; Enalaprilat; Glutathione; Kidney; Lipid Peroxidation; Male; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Time Factors

1992
Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 257, Issue:3

    Topics: Acetylcholine; Acetylcysteine; Animals; Captopril; Cyclic GMP; Enalaprilat; Endothelium, Vascular; Glutathione; In Vitro Techniques; Nitric Oxide; Norepinephrine; Pyrogallol; Rabbits; Structure-Activity Relationship; Sulfhydryl Compounds; Superoxide Dismutase; Tiopronin; Vasodilation

1991
Captopril-induced reversal of nitroglycerin tolerance: role of sulfhydryl group vs. ACE-inhibitory activity.
    Journal of cardiovascular pharmacology, 1991, Volume: 17, Issue:3

    Topics: Acetylcholine; Acetylcysteine; Animals; Aorta; Captopril; Cyclic GMP; Drug Tolerance; Enalaprilat; Nitroglycerin; Rats; Rats, Inbred Strains; Sulfhydryl Compounds; Vasodilation

1991
Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 258, Issue:3

    Topics: Acetylcysteine; Blood Platelets; Captopril; Drug Synergism; Enalaprilat; Endothelium, Vascular; Humans; Iloprost; Nitric Oxide; Nitroprusside; Nucleotides, Cyclic; Platelet Aggregation Inhibitors; Sulfhydryl Compounds; Teprotide; Thrombin

1991
N-acetyl-L-cysteine potentiates depressor response to captopril and enalaprilat in SHRs.
    The American journal of physiology, 1994, Volume: 267, Issue:3 Pt 2

    Topics: Acetylcysteine; Animals; Blood Pressure; Captopril; Drug Synergism; Enalaprilat; Hypertension; Male; Rats; Rats, Inbred SHR

1994
Inhibitory effects of enalaprilat on rat cardiac fibroblast proliferation via ROS/P38MAPK/TGF-β1 signaling pathway.
    Molecules (Basel, Switzerland), 2012, Mar-06, Volume: 17, Issue:3

    Topics: Acetylcysteine; Active Transport, Cell Nucleus; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Enalaprilat; Fibroblasts; Gene Expression; Imidazoles; MAP Kinase Signaling System; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenols; Phosphorylation; Plant Extracts; Pyridines; Rats; Rats, Inbred WKY; Reactive Oxygen Species; Transforming Growth Factor beta1

2012